Emerging treatment options for advanced esophageal squamous cell carcinoma: an interview with Ken Kato

Written by Ken Kato (National Cancer Center Hospital, Tokyo, Japan)

esophageal cancer

Please introduce yourself, your research background and current research interests. My name is Ken Kato and I am a gastrointestinal oncologist at the National Cancer Center Hospital (Tokyo, Japan). My special interest is esophageal cancer, especially squamous cell carcinoma and gastric cancer, but I have conducted many clinical trials for esophageal cancer. For example, the Phase II trial of chemoradiotherapy for esophageal squamous cell carcinoma (ESCC). I am the group coordinator of the Japan Clinical Oncology Group esophageal cancer study group and I am the Principle Investigator for the Phase III trial of the comparison of neoadjuvant chemotherapy and adjuvant...

To view this content, please register now for access

It's completely free